Used as a chiral catalyst or ligand in asymmetric synthesis, particularly in enantioselective hydrogenation and C–C bond-forming reactions. Its oxazoline-pyridine framework coordinates well with transition metals like palladium, nickel, and iridium, enhancing stereochemical control in the production of pharmaceutical intermediates and fine chemicals. Commonly applied in the development of optically active compounds for drug synthesis, especially where high enantiomeric excess is required. Also employed in research settings for designing catalysts with improved selectivity and reactivity under mild reaction conditions.